Granules India Ltd share price logo

Granules India Share Price

NSE: GRANULES

BSE: 532482

Small Cap

Healthcare Sector

₹624.35

-4.70

(-0.75%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Granules India Stock Performance

as on March 27, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹619.00
    ₹632.35
    downward going graph

    0.86%

    Downside

    1.28%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹422.00
    ₹632.35
    downward going graph

    32.41%

    Downside

    1.28%

    Upside

    downward going graph

Granules India share price movements today

Previous Close
₹629.05
Open
₹629.10
Volume
9.11L
Upper Circuit
₹754.85
Lower Circuit
₹503.25
Day's Low - High
₹619.00 - ₹632.35
52 Week Low - High
₹422.00 - ₹632.35

Granules India Historical Returns

1 Month Return
+ 8.04 %
3 Month Return
+ 4.29 %
1 Year Return
+ 28.27 %
3 Year Return
+ 121.77 %
5 Year Return
+ 103.51 %

Granules India Fundamentals

as on March 27, 2026 at 4:01 pm IST

Market Cap

₹15,265.08 Cr

Return on Equity (ROE)

9.8

PE Ratio (TTM)

27.98

Return on capital employed (ROCE)

11.47

Industry PE ratio

40.67

Beta (LTM)

1.24

P/B Ratio

3.47

Dividend Yield

0.31

PEG Ratio

10.33

Quarterly Earnings Growth YOY

27.73

EPS (TTM)

20.68

Sector

Pharmaceuticals

Book Value

153.19

Technical Analysis

Bullish

View Technical Analysis

Granules India Stock Valuation

as on March 27, 2026 at 4:01 pm IST

Granules India in the last 5 years

  • Overview

  • Trends

Lowest (8.05x)

July 25, 2019

Today (27.98x)

March 25, 2026

Industry (40.67x)

March 25, 2026

Highest (35.36x)

August 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 27.98x

Granules India Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Granules India with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Granules India Ltd image
Granules India Ltd
BUY15,265.0820.7%0.645014,481
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY11,712.29-7.24%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY13,695.024.36%0.718367,234
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
BUY4,265.84-1.86%1.88-34371
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY11,866.1731.91%0.672441,515
See all

Market expectation of Granules India Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Granules India Stock’s Investor Sentiment and Interest

Search interest for Granules India Ltd Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-10% versus previous 30 day period

Granules India Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
1,195.5
983.39
1,188
1,149.71
1,169.06
1,169.11
956.52
1,133.52
1,196.82
1,208.79
1,294.67
1,378.02
Other Income
3.38
0.35
1.53
0.65
1.87
2.06
3.26
5.68
32.67
16.35
-1.15
-3.64
Total Income
1,198.88
985.86
1,191.02
1,156.24
1,177.65
1,181.93
969.87
1,143.37
1,230.1
1,226.45
1,295.84
1,384.3
Expenses
967.38
848.69
976.51
905.1
920.08
920.6
763.3
907.41
945.07
989.3
1,018.76
1,079.84
Operating Profit
228.12
134.7
211.49
244.61
248.98
248.51
193.22
226.11
251.75
219.49
275.91
298.18
Operating Profit Margin %
19.08%
13.7%
17.8%
21.28%
21.3%
21.26%
20.2%
19.95%
21.03%
18.16%
21.31%
21.64%
Profit Before Interest, Tax and Depreciation
231.49
137.17
214.5
251.13
257.58
261.33
206.57
235.97
285.03
237.15
277.08
304.46
Interest
18.8
22.46
25.96
28.65
28.76
27.02
25.67
26.57
23.98
23.78
29.19
28.69
Depreciation
48.71
49.24
52.52
52.39
53.18
52.87
52.52
56.61
63.5
68.85
72.02
73.53
Profit Before Tax
163.98
65.47
136.02
170.09
175.64
181.44
128.38
152.79
197.55
144.52
175.87
202.24
Tax Paid
44.38
17.58
33.91
44.45
46
46.79
31.15
35.19
45.52
31.88
45.26
52.03
Profit After Tax
119.61
47.9
102.12
125.65
129.65
134.65
97.23
117.6
152.03
112.64
130.61
150.21
Total Net profit including share of profit / Loss from associate company
119.61
47.9
102.12
125.65
129.65
134.65
97.23
117.6
152.03
112.64
130.61
150.21
EPS
4.94
1.98
4.22
5.18
5.35
5.56
4.01
4.85
6.27
4.64
5.38
6.19
Actual EPS
4.94
1.98
4.22
5.18
5.35
5.56
4.01
4.85
6.27
4.64
5.38
6.19
Adjusted EPS
4.94
1.98
4.22
5.18
5.35
5.56
4.01
4.85
6.27
4.64
5.38
6.19
Diluted EPS
4.93
1.98
4.22
5.18
5.35
5.55
4.01
4.85
6.27
4.64
5.38
6.19

Granules India Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
1,410.57
1,684.62
2,279.2
2,598.65
3,237.54
3,764.92
4,511.92
4,490.16
4,455.97
Other Income
9.93
26.83
75.43
89.79
26.88
17.61
13.78
4.4
43.67
Total Income
1,420.49
1,711.45
2,354.62
2,688.43
3,264.42
3,782.53
4,525.7
4,510.77
4,525.28
Expenses
1,111.73
1,406.2
1,895.16
2,073.33
2,382.31
3,042.68
3,598.1
3,650.39
3,536.37
Operating Profit
298.84
278.42
384.04
525.32
855.23
722.24
913.82
839.77
919.6
Operating Profit Margin %
21.19%
16.53%
16.85%
20.22%
26.42%
19.18%
20.25%
18.7%
20.64%
Profit Before Interest, Tax and Depreciation
308.76
305.25
459.46
615.1
882.11
739.85
927.6
860.38
988.91
Interest
32.26
33.06
28.46
27.02
26.28
23.21
55.93
105.82
103.24
Depreciation
71.51
76.2
105.48
136.95
151.46
158.63
184.49
207.33
225.5
Profit Before Tax
204.99
195.99
325.52
451.13
704.37
558.01
687.18
547.23
660.17
Tax Paid
65.2
63.4
89.11
115.73
154.9
145.25
170.58
141.92
158.65
Profit After Tax
139.79
132.59
236.41
335.4
549.46
412.76
516.6
405.31
501.52
Total Net profit including share of profit / Loss from associate company
164.52
132.59
236.41
335.4
549.46
412.76
516.6
405.31
501.52
EPS
7.52
5.49
9.3
13.19
22.05
16.66
21.05
16.73
20.69
Actual EPS
7.52
5.49
9.3
13.19
22.05
16.66
21.05
16.73
20.69
Adjusted EPS
7.52
5.49
9.3
13.19
22.05
16.66
21.05
16.73
20.69
Diluted EPS
7.48
5.47
9.28
13.15
21.95
16.6
21
16.72
20.68

Granules India Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
151.43
188.24
-0.65
262.24
476.19
432.48
332.05
738.75
439.41
866.57
Cash Flow from Investing Activities
-161.65
-326.08
-462.31
-269.81
-160.42
-277.25
-379.17
-191.62
-357.54
-689.04
Cash Flow from Financing Activities
85.66
55.88
528.61
-17.43
-212.86
-299.31
190
-440.31
7.65
-92.5
Net Cash Flow
75.44
-81.98
65.66
-25.01
102.9
-144.09
142.88
106.84
89.54
85.01

Granules India Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Feb 2026
Promoters
42.02%
41.96%
41.96%
41.96%
38.87%
38.87%
38.85%
38.84%
38.82%
38.82%
38.82%
38.02%
DII
6.68%
6.85%
10.14%
10.7%
14.12%
14.87%
19.57%
22.45%
22.74%
17.92%
17.48%
18.51%
FII
0%
0%
0%
19.57%
20.39%
19.49%
15.87%
15.15%
0%
14.09%
13.55%
13.79%
Public
29.95%
29.5%
29.1%
27.76%
26.62%
26.78%
25.71%
23.57%
24.41%
29.17%
30.15%
29.69%
Total Outstanding Shares
24,20,42,756
24,23,68,716
24,23,68,716
24,23,68,716
24,23,68,716
24,23,68,716
24,24,93,716
24,25,43,716
24,26,43,716
24,26,68,716
24,26,68,716
24,77,96,921
Total Shareholders
2,01,054
2,07,055
1,90,691
1,82,142
1,79,870
2,02,198
1,77,554
1,69,802
1,69,700
1,65,542
1,63,184
1,63,818

Mutual Funds that own Granules India Stock

Check out the Mutual Funds with significant holdings in Granules India.

Granules India Corporate Actions

View detailed summary of the earnings and dividend history of Granules India.

  • Granules India Ltd Earnings Results

    Granules India Ltd’s net profit jumped 27.73% since last year same period to ₹150.21Cr in the Q3 2025-2026. On a quarterly growth basis, Granules India Ltd has generated 15.01% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Granules India Ltd Dividends May,2025

    In the quarter ending March 2025, Granules India Ltd has declared dividend of ₹1.50 per share on 28 May 2025 - translating a dividend yield of 0.24%.

    Read More about Dividends

Granules India News & Key Events

  • img

    Today's Timeline - 27 March

    06:27 AM

    -

    Granules India shows positive technical structure, indicating bullish momentum and potential for fresh upside momentum.

Indices Featuring Granules India Stock

Check stock indices that include Granules India.

Nifty 500

₹21,020.15

-2.13 (▲458.05%)

S&P BSE 250 SmallCap

₹5,795.67

-1.82 (▲107.32%)

Nifty Smallcap 250

₹14,655.35

-1.89 (▲281.85%)

BSE Healthcare

₹42,427.96

-0.73 (▲311.37%)

Nifty MidSmallcap 400

₹17,988.25

-2.08 (▲382.50%)

S&P BSE 400 MidSmallCap

₹10,738.13

-2.06 (▲226.12%)

BSE 500

₹32,935.19

-2.11 (▲710.70%)

Insights on Granules India Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 1.22K Cr → 1.38K Cr (in ₹), with an average increase of 5.9% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 112.64 Cr → 150.21 Cr (in ₹), with an average increase of 13.4% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, GRANULES stock has moved up by 6.5%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 13.55% to 13.79% in Feb 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 179.8% return, outperforming this stock by 58.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 32.9% return, outperforming this stock by 4.7%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 38.82% to 38.02% in Feb 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 30.15% to 29.69% in Feb 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 5.35% to 4.28% in Feb 2026 quarter

About Granules India Ltd

Granules India Limited is a large-scale vertically-integrated company found in March 1991. It manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages. The company has a strong presence in off-patent drugs, first-line defence products such as Paracetamol, Ibuprofen, Metformin, and Guaifenesin, as well as a global presence in over 80 countries and 250 customers. It also has a 15,000 sq. ft. research center in Pragathi Nagar, Hyderabad and has completed expansion projects in Gagillapur and Visakhapatnam. In FY 2014-15, the company crossed Rs 1200 crore in revenue, made its first acquisition, and increased its PFI capacity by 4000 tons / annum. During 2015-16 it initiated construction of 7000 TPA Metformin and 2000 TPA Guaifenesin API block, and has a total of 22 EDMF/CEP and 44 ANDA filings with US FDA. In FY 2017 the company received Establishment Inspection Report from US FDA for its Jeedimetla plant and license from the Drug Enforcement Agency for its Virginia facility. In FY 2018, it crossed Rs 1400 crore in revenue and initiated commercial production of Metaformin and Paracetamol API at its Bonthapally facility. The company also successfully received 7 ANDAs approvals from US FDA. In FY 2019, Granules India initiated buyback programme, with the Board of Directors approving a buyback of up to 12.5 million equity shares on 21 January 2020. The Company has divested its entire 50% shareholding in GranulesBiocause Pharmaceutical Co. Ltd and Granules Omnichem Private Ltd. for a consideration of Rs 111.2 crore. During the year 2021, Granules Pharmaceuticals Inc. announced a voluntary recall of 12 batches of Metformin Hydrochloride Extended Release tablets USP 750 mg, out of caution. In 2022, the Company completed the largest single manufacturing site for Multiple Unit Pellet System MUPS at its Gagillapur facility and capacity expansion for manufacturing multiple APIs at Unit V Visakhapatnam. In a span of over 30 years, Granules India has firmly established its leadership in the off-patent drugs segment, and a strong presence in first line of defense products, creating a global presence in over 80 countries, servicing over 250 customers and filing 66 EDMF/CE

Revenue: ₹1,378.02Cr as on December 2025 (Q3 FY26)
Net Profit: ₹150.21Cr as on December 2025 (Q3 FY26)
Listing date: 20 Jun, 2005
Chairperson Name: C Krishna Prasad
OrganisationGranules India Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOC Krishna Prasad
E-voting on sharesClick here to vote

FAQs

What is Granules India share price today?

Granules India share price today stands at ₹624.35 as on at the close of the market. Granules India share today touched a day high of ₹632.35 and a low of ₹619.

What is the 52 week high and 52 week low range for Granules India share?

Granules India touched a 52 week high of ₹632.35 and a 52 week low of ₹422. Granules India share price today i.e. is closed at ₹624.35, which is -1.27% down from its 52 week high and 47.95% up from its 52 week low.

What is Granules India's market capitalisation today?

Granules India market capitalisation is ₹15,265.08 Cr as on .

How to buy Granules India shares?

To buy Granules India shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for GRANULES or Granules India Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Granules India shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Granules India trading volume today?

Granules India trading volume is 9.11L as on . This means that 9.11L shares of Granules India were bought and sold on the stock market during today's trading session.